With over 40 years’ experience in aesthetics, Galderma has developed an industry-leading neuromodulator portfolio which is underscored by the data presented at the TOXINS 2024 International Conference. More details on Galderma’s scientific posters at TOXINS 2024 can be found below.
|
First Author |
Abstract title |
Poster # All posters can be viewed in the Poster Hall |
|
RelabotulinumtoxinA |
||
|
V. Bertucci |
Efficacy and safety of a novel formulation liquid botulinum toxin, RelabotulinumtoxinA, when used for combination treatment of glabellar and lateral canthal lines (READY-3) |
Poster 0074 |
|
N. Solish |
Treatment of moderate-to-severe glabellar lines with RelabotulinumtoxinA, an investigational liquid botulinum toxin: clinical efficacy and safety results from the READY-1 phase III trial |
Poster 0023 |
|
G. Ablon |
Treatment of lateral canthal lines with RelabotulinumtoxinA, an investigational liquid botulinum toxin: clinical efficacy and safety results from the READY-2 phase III trial |
Poster 0103 |
|
AbobotulinumtoxinA |
|
|
|
C. Persson |
Patient and investigator treatment experience with ready-to-use AbobotulinumtoxinA solution versus powder BotulinumtoxinA for treatment of glabellar Lines |
Poster 0174 |
|
C. Persson |
A real-world study of patient and physician satisfaction with AbobotulinumtoxinA treatment of glabellar lines in Chinese patients |
Poster 0173 |